The Center for Translational Pain Medicine (CTPM) is transforming the way we study, diagnose, and treat painful conditions. The CTPM brings together, under one umbrella, a diverse team of basic science and clinical researchers with complementary expertise in pain neurobiology, molecular genetics, neuroimaging, epidemiology, and bioinformatics to make exciting new discoveries in the areas of pain mechanisms and management. The CTPM extends into Duke Anesthesiology’s clinical innovative pain therapy program to achieve a common core mission of improving patient care.

Updates & Announcements

Duke Anesthesiology Awarded Program Project Grant

Two CTPM Faculty Awarded a 2020 DREAM Innovation Grant

Pain Journal Club
First Friday of the month
12 – 1 PM | GSRBIII 6130

Stay up-to-date on the latest pain-related news, research & events:
USASP | IASP | NIH Pain Consortium | Pain Research Forum

Tradition • Innovation • Translation

CTPM News

Dr. Achanta Awarded Grant for Novel Approach to ARDS

Congratulations to Satya Achanta, DVM, PhD, on being awarded a $199,962 grant to assess a novel intravascular membrane oxygen catheter, which may be beneficial for patients with acute respiratory distress syndrome (ARDS).

Duke Anesthesiologist Among World’s Most-Cited Scholars

Congratulations to Dr. Ru-Rong Ji, professor in anesthesiology, on once again making Clarivate’s prestigious list of the most highly-cited researchers in the world. He is one of 23 Duke scientists and 6,886 global researchers on the 2024 list.

Studying Spinal Cord Stimulation to Treat Lower Back Pain

Congratulations to Dr. Satya Achanta on receiving an industry-sponsored grant to evaluate the use of a non-pharmacological therapy to treat lower back pain, which affects a significant number of adults in the United States.

Studying Spinal Cord Stimulation to Treat Lower Back Pain

Congratulations to Dr. Satya Achanta on receiving a $199,756 industry-sponsored grant to evaluate the use of a non-pharmacological therapy to treat lower back pain, which affects a significant number of adults in the United States.

Examining the Impact of New Tobacco Product Designs

Congratulations to Dr. Sven-Eric Jordt on receiving a $2,395,528 R01 National Institutes of Health grant to investigate the composition of novel tobacco products and their potential role in facilitating nicotine addiction.

Pioneering Treatments for Phosgene Inhalation Injuries

Congratulations to Dr. Satya Achanta on being awarded a $1,109,637 UG3 grant from the National Institutes of Health for his research that could mark a pivotal advancement in targeted treatments for injuries from phosgene gas, a terrorism and warfare agent.